India, Aug. 5 -- Cipla announced that the United States Food and Drug Administration has classified the current Good Manufacturing Practices inspection of the company's manufacturing facility in Bommasandra, Bengaluru as Voluntary Action Indicated (VAI).
Published by HT Digital Content Services with permission from Pivotal Sources....